4.6 Review

The Road to Dissemination: The Concept of Oligometastases and the Barriers for Widespread Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Tumour-agnostic circulating tumour DNA analysis for improved recurrence surveillance after resection of colorectal liver metastases: A prospective cohort study

Nadia Ogaard et al.

Summary: Serial postoperative ctDNA analysis has strong prognostic value and is more sensitive for recurrence detection than standard-of-care CRLM surveillance tools. TriMeth provides several opportunities for improving postoperative surveillance of CRLM patients.

EUROPEAN JOURNAL OF CANCER (2022)

Article Medicine, Research & Experimental

Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic Cancer and Brain Involvement

Carsten Nieder et al.

Summary: This study aimed to evaluate the prognostic impact of LabBM score in patients with brain metastases. The results showed that patients with lower LabBM score had significantly longer survival. LabBM score, clinical status, and number of brain metastases were significantly associated with survival. These findings can help guide the treatment strategy for patients with brain metastases.

IN VIVO (2022)

Review Oncology

Squeezing through the microcirculation: survival adaptations of circulating tumour cells to seed metastasis

Julia Perea Paizal et al.

Summary: This passage explores the impact of mechanical constriction on tumor cells during metastasis, including how forces exerted by capillaries may induce adaptive mechanisms in circulating tumor cells (CTCs) to enhance survival and metastatic potential. The study also highlights how advancements in microfluidics have provided insights into the adaptations developed by CTCs in response to mechanical constraints in the microvasculature, and how these forces may trigger dynamic changes towards a more invasive phenotype in the cells. Understanding the dynamic mechanisms adopted by CTCs within the microcirculation could potentially lead to the development of novel therapeutic approaches for metastatic cancers.

BRITISH JOURNAL OF CANCER (2021)

Review Oncology

Steps in metastasis: an updated review

Jamal Majidpoor et al.

Summary: Metastasis is a complex and deadly process involving various mechanisms and influencing factors. It can be targeted through strategies such as repressing pre-metastatic niche formation, suppressing environmental stressors, and targeting signaling pathways and cell types involved in the process.

MEDICAL ONCOLOGY (2021)

Article Oncology

Liquid Biopsy Cell-free DNA Biomarkers in Patients With Oligometastatic Colorectal Cancer Treated by Ablative Radiotherapy

Masaki Nakamura et al.

Summary: Analyzing cfDNA in oligometastatic colorectal cancer patients can predict the early recurrence after radiotherapy. The clonality of gene mutations may be associated with patient prognosis, and the presence of cfDNA has a significant correlation with PFS in patients with lung metastases.

ANTICANCER RESEARCH (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer

Martina Sollini et al.

Summary: This study evaluated image-derived biomarkers in patients with recurrent oligometastatic and plurimetastatic Prostate Cancer, finding differences in lesion similarity. The results supported the use of a three-lesion threshold to define oligometastatic PCa.

EJNMMI RESEARCH (2021)

Review Oncology

Organ tropism in solid tumor metastasis: an updated review

Keywan Mortezaee

Summary: Tumors of solid organs have a tendency to metastasize to specific organs, relying on the plasticity of tumor cells to reshape their epigenetic landscape and successfully colonize new areas.

FUTURE ONCOLOGY (2021)

Review Oncology

Metastasis-Initiating Cells and Ecosystems

Joan Massague et al.

Summary: Metastasis-initiating cells (MIC) are cancer cells with stem-like and immune-evasive properties that adopt regenerative progenitor phenotypes, enabling them to survive the stresses of metastasis and evade immune surveillance. Understanding the molecular mechanisms of MIC phenotypes and host tissue ecosystems is crucial for developing improved cancer therapeutics.

CANCER DISCOVERY (2021)

Article Oncology

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative

Philippe Aftimos et al.

Summary: The AURORA program conducted genomic and transcriptomic analyses on matched primary and metastatic samples from 381 breast cancer patients, identifying genomic alterations enriched in metastases and prognostic biomarkers. Over half of the patients had ESCAT tier I/II alterations detected.

CANCER DISCOVERY (2021)

Review Oncology

Diagnostic and prognostic biomarkers in oligometastatic non-small cell lung cancer: a literature review

Diego Cortinovis et al.

Summary: This review discusses the potential of molecular diagnostic techniques in lung cancer, particularly in oligometastatic disease. The advancements in liquid biopsy techniques show promise in early diagnosis and better treatment decisions for OM-NSCLC, ultimately improving patient outcomes.

TRANSLATIONAL LUNG CANCER RESEARCH (2021)

Article Oncology

Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases

Fotios Loupakis et al.

Summary: This study suggests that ctDNA-based MRD analysis is a significant prognostic biomarker in patients with metastatic colorectal cancer undergoing resection, providing valuable information for clinical decision making, clinical trial design, and translational research.

JCO PRECISION ONCOLOGY (2021)

Article Medicine, Research & Experimental

Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases

De-Shen Wang et al.

Summary: This study found that ctDNA analysis can be used to predict the prognosis of patients undergoing resection of CRLM. Patients with a higher baseline ctDNA variant allele frequency represent a higher tumor burden, while decreased ctDNA during pre-operative chemotherapy predicted better tumor response. Patients with detectable ctDNA post-operatively and after adjuvant chemotherapy were associated with significantly shorter recurrence-free survival.

THERANOSTICS (2021)

Article Medicine, General & Internal

BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancer

Pashtoon Murtaza Kasi et al.

Summary: This study investigates the clinical utility of ctDNA in optimizing adjuvant chemotherapy for surgically resected CRC patients and detecting early disease progression. Bespoke ctDNA testing impact on adjuvant treatment decisions and monitoring CRC recurrence rates are the primary endpoints of the study.

BMJ OPEN (2021)

Article Oncology

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine

Bruna Pellini et al.

Summary: This study aimed to evaluate the use of ctDNA analysis after neoadjuvant chemotherapy in patients with oligometastatic colorectal cancer. The research found that plasma ctDNA analysis can sensitively detect MRD, while urine-based detection, although feasible, is less sensitive.

JCO PRECISION ONCOLOGY (2021)

Article Multidisciplinary Sciences

A metastasis map of human cancer cell lines

Xin Jin et al.

NATURE (2020)

Review Oncology

Circulating Tumor DNA Biomarkers for Early Detection of Oligometastasis

David M. Routman et al.

CANCER JOURNAL (2020)

Review Biochemistry & Molecular Biology

Molecular principles of metastasis: a hallmark of cancer revisited

Jawad Fares et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Multidisciplinary Sciences

Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis

Sean P. Pitroda et al.

NATURE COMMUNICATIONS (2018)

Review Oncology

Pre-metastatic niches: organ-specific homes for metastases

Hector Peinado et al.

NATURE REVIEWS CANCER (2017)

Review Biochemistry & Molecular Biology

Emerging Biological Principles of Metastasis

Arthur W. Lambert et al.

Article Oncology

Imaging oligometastatic cancer before local treatment

James M. Franklin et al.

LANCET ONCOLOGY (2016)

Article Cell Biology

Roles for E-cadherin cell surface regulation in cancer

Yuliya I. Petrova et al.

MOLECULAR BIOLOGY OF THE CELL (2016)

Review Multidisciplinary Sciences

Metastatic colonization by circulating tumour cells

Joan Massague et al.

NATURE (2016)

Article Oncology

Motion management during SBRT for oligometastatic cancer: Results of a prospective phase II trial

Robbe Van den Begin et al.

RADIOTHERAPY AND ONCOLOGY (2016)

Review Multidisciplinary Sciences

Metastasis as an evolutionary process

Samra Turajlic et al.

SCIENCE (2016)

Review Multidisciplinary Sciences

Hypoxic control of metastasis

Erinn B. Rankin et al.

SCIENCE (2016)

Article Oncology

Inferring the Origin of Metastases from Cancer Phylogenies

Woo Suk Hong et al.

CANCER RESEARCH (2015)

Article Multidisciplinary Sciences

The evolutionary history of lethal metastatic prostate cancer

Gunes Gundem et al.

NATURE (2015)

Article Oncology

14q32-encoded microRNAs mediate an oligometastatic phenotype

Abhineet Uppal et al.

ONCOTARGET (2015)

Review Oncology

Surviving at a Distance: Organ-Specific Metastasis

Anna C. Obenauf et al.

TRENDS IN CANCER (2015)

Article Oncology

The oligometastatic state-separating truth from wishful thinking

David A. Palma et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2014)

Review Oncology

Origins of Metastatic Traits

Sakari Vanharanta et al.

CANCER CELL (2013)

Article Medicine, Research & Experimental

Tracking the clonal origin of lethal prostate cancer

Michael C. Haffner et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Oncology

Stereotactic body radiotherapy for oligometastases

Alison C. Tree et al.

LANCET ONCOLOGY (2013)

Review Biochemistry & Molecular Biology

Tumor metastasis: moving new biological insights into the clinic

Liling Wan et al.

NATURE MEDICINE (2013)

Review Medicine, General & Internal

The Implications of Clonal Genome Evolution for Cancer Medicine

Samuel Aparicio et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, General & Internal

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Marco Gerlinger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Oncology

Oligometastases revisited

Ralph R. Weichselbaum et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2011)

Article Multidisciplinary Sciences

MicroRNA Expression Characterizes Oligometastasis(es)

Yves A. Lussier et al.

PLOS ONE (2011)

Article Multidisciplinary Sciences

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

Peter J. Campbell et al.

NATURE (2010)

Article Multidisciplinary Sciences

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

Shinichi Yachida et al.

NATURE (2010)

Review Immunology

Role of macrophages in tumour progression

K. S. Siveen et al.

IMMUNOLOGY LETTERS (2009)

Review Biochemistry & Molecular Biology

Cancer metastasis:: Building a framework

Gaorav P. Gupta et al.

Review Oncology

Dissemination and growth of cancer cells in metastatic sites

AF Chambers et al.

NATURE REVIEWS CANCER (2002)

Review Oncology

Platelets and cancer

GF Nash et al.

LANCET ONCOLOGY (2002)

Review Oncology

Hypoxia - A key regulatory factor in tumour growth

AL Harris

NATURE REVIEWS CANCER (2002)

Review Biochemistry & Molecular Biology

Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis

A Saaristo et al.

ONCOGENE (2000)

Review Biochemistry & Molecular Biology

The hallmarks of cancer

D Hanahan et al.